Nitric Oxide-Induced Down-Regulation of β-Catenin in Colon Cancer Cells by a Proteasome-Independent Specific Pathway

Gastroenterology

Volumn 131, Issue 4, 2006, Pages 1142-1152

  Prévotat, Laurent ^a   Filomenko, Rodolphe ^a   Solary, Eric ^a   Jeannin, Jean François ^a   Bettaieb, Ali ^a  

^a PSL RESEARCH UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BETA GALACTOSIDASE; CASPASE INHIBITOR; FLUORIDE; GLYCERYL TRINITRATE; LUCIFERASE; NITRIC OXIDE; PROTEASOME; SERINE; SERINE PROTEINASE INHIBITOR; THREONINE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TYROSINE; UBIQUITIN;

ARTICLE; CANCER CELL CULTURE; DEGRADATION; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; METHODOLOGY; NITRATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 33749465610     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.07.017     Document Type: Article

References (54)

1. Ben-Ze'ev A., and Geiger B. Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer. Curr Opin Cell Biol 10 (1998) 629-639
2. Gumbiner B.M. Signal transduction of β-catenin. Curr Opin Cell Biol 7 (1995) 634-640
3. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., and He X. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108 (2002) 837-847
4. Kishida S., Yamamoto H., Ikeda S., Kishida M., Sakamoto I., Koyama S., and Kikuchi A. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin. J Biol Chem 273 (1998) 10823-10826
5. Hart M., Concordet J.P., Lassot I., Albert I., del los Santos R., Durand H., Perret C., Rubinfeld B., Margottin F., Benarous R., and Polakis P. The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell. Curr Biol 9 (1999) 207-210
6. Maniatis T. A ubiquitin ligase complex essential for the NF-κB, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev 13 (1999) 505-510
7. Aberle H., Bauer A., Stappert J., Kispert A., and Kemler R. β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16 (1997) 3797-3804
8. Li L., Yuan H., Weaver C.D., Mao J., Farr III G.H., Sussman D.J., Jonkers J., Kimelman D., and Wu D. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J 18 (1999) 4233-4240
9. Crawford H.C., Fingleton B.M., Rudolph-Owen L.A., Goss K.J., Rubinfeld B., Polakis P., and Matrisian L.M. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene 18 (1999) 2883-2891
10. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., and Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509-1512
11. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., and Kinzler K.W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275 (1997) 1787-1790
12. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., and Clevers H. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 275 (1997) 1784-1787
13. Parker M.C. Early postoperative feeding after elective colorectal surgery is not a benefit unique to laparoscopy-assisted procedures. Int J Colorectal Dis 12 (1997) 51-52
14. Kolligs F.T., Bommer G., and Goke B. Wnt/β-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66 (2002) 131-144
15. Brancolini C., Lazarevic D., Rodriguez J., and Schneider C. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of β-catenin. J Cell Biol 139 (1997) 759-771
16. Nath N., Labaze G., Rigas B., and Kashfi K. NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression. Biochem Biophys Res Commun 326 (2005) 93-99
17. Steinhusen U., Badock V., Bauer A., Behrens J., Wittman-Liebold B., Dorken B., and Bommert K. Apoptosis-induced cleavage of β-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential. J Biol Chem 275 (2000) 16345-16353
18. Li G., and Iyengar R. Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/β-catenin-regulated cell proliferation. Proc Natl Acad Sci U S A 99 (2002) 13254-13259
19. Adrain C., Creagh E.M., and Martin S.J. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 20 (2001) 6627-6636
20. Millet A., Bettaieb A., Renaud F., Prevotat L., Hammann A., Solary E., Mignotte B., and Jeannin J.F. Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells. Gastroenterology 123 (2002) 235-246
21. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6 (1992) 3051-3064
22. Ignarro L.J. Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension 16 (1990) 477-483
23. Dimmeler S., Haendeler J., Nehls M., and Zeiher A.M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 185 (1997) 601-607
24. Messmer U.K., Ankarcrona M., Nicotera P., and Brune B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 355 (1994) 23-26
25. Kim Y.M., Kim T.H., Seol D.W., Talanian R.V., and Billiar T.R. Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J Biol Chem 273 (1998) 31437-31441
26. Stamler J.S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78 (1994) 931-936
27. Matsumoto A., Comatas K.E., Liu L., and Stamler J.S. Screening for nitric oxide-dependent protein-protein interactions. Science 301 (2003) 657-661
28. Scott D.J., Hull M.A., Cartwright E.J., Lam W.K., Tisbury A., Poulsom R., Markham A.F., Bonifer C., and Coletta P.L. Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse. Gastroenterology 121 (2001) 889-899
29. Jeannin J.F., Onier N., Lagadec P., von Jeney N., Stutz P., and Liehl E. Antitumor effect of synthetic derivatives of lipid A in an experimental model of colon cancer in the rat. Gastroenterology 101 (1991) 726-733
30. Onier N., Hilpert S., Reveneau S., Arnould L., Saint-Giorgio V., Exbrayat J.M., and Jeannin J.F. Expression of inducible nitric oxide synthase in tumors in relation with their regression induced by lipid A in rats. Int J Cancer 81 (1999) 755-760
31. Rao C.V. Nitric oxide signaling in colon cancer chemoprevention. Mutat Res 555 (2004) 107-119
32. Yasuda H., Yamaya M., Nakayama K., Sasaki T., Ebihara S., Kanda A., Asada M., Inoue D., Suzuki T., Okazaki T., Takahashi H., Yoshida M., Kaneta T., Ishizawa K., Yamanda S., Tomita N., Yamasaki M., Kikuchi A., Kubo H., and Sasaki H. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer. J Clin Oncol 24 (2006) 688-694
33. Shih I.M., Yu J., He T.C., Vogelstein B., and Kinzler K.W. The β-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Cancer Res 60 (2000) 1671-1676
34. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
35. Reidlinger J., Pike A.M., Savory P.J., Murray R.Z., and Rivett A.J. Catalytic properties of 26S and 20S proteasomes and radiolabeling of MB1, LMP7, and C7 subunits associated with trypsin-like and chymotrypsin-like activities. J Biol Chem 272 (1997) 24899-24905
36. Pfeiffer S., Leopold E., Hemmens B., Schmidt K., Werner E.R., and Mayer B. Interference of carboxy-PTIO with nitric oxide- and peroxynitrite-mediated reactions. Free Radic Biol Med 22 (1997) 787-794
37. Deng J., Miller S.A., Wang H.Y., Xia W., Wen Y., Zhou B.P., Li Y., Lin S.Y., and Hung M.C. β-Catenin interacts with and inhibits NF-κB in human colon and breast cancer. Cancer Cell 2 (2002) 323-334
38. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., and Hedge P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253 (1991) 665-669
39. Polakis P. Wnt signaling and cancer. Genes Dev 14 (2000) 1837-1851
40. Reinheckel T., Sitte N., Ullrich O., Kuckelkorn U., Davies K.J., and Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335 Pt 3 (1998) 637-642
41. Sutherland C., Leighton I.A., and Cohen P. Inactivation of glycogen synthase kinase-3 β by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296 Pt 1 (1993) 15-19
42. Hwang S.G., Lee H.C., Trepel J.B., and Jeon B.H. Anticancer-drug-induced apoptotic cell death in leukemia cells is associated with proteolysis of β-catenin. Leuk Res 26 (2002) 863-871
43. Kaminaga N., Parra-Blanco A., and Fujita R. Colonic side effects of nonsteroidal anti-inflammatory drugs. Intern Med 38 (1999) 219-220
44. Dihlmann S., Siermann A., and von Knebel Doeberitz M. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling. Oncogene 20 (2001) 645-653
45. Gao J., Liu X., and Rigas B. Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc Natl Acad Sci U S A 102 (2005) 17207-17212
46. Nath N., Kashfi K., Chen J., and Rigas B. Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin-TCF association. Proc Natl Acad Sci U S A 100 (2003) 12584-12589
47. Yoshimoto M., Itoh F., Yamamoto H., Hinoda Y., Imai K., and Yachi A. Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers. Int J Cancer 54 (1993) 614-618
48. Piedra J., Miravet S., Castano J., Palmer H.G., Heisterkamp N., Garcia de Herreros A., and Dunach M. p120 Catenin-associated Fer and Fyn tyrosine kinases regulate β-catenin Tyr-142 phosphorylation and β-catenin-α-catenin interaction. Mol Cell Biol 23 (2003) 2287-2297
49. Roura S., Miravet S., Piedra J., Garcia de Herreros A., and Dunach M. Regulation of E-cadherin/catenin association by tyrosine phosphorylation. J Biol Chem 274 (1999) 36734-36740
50. Herren B., Levkau B., Raines E.W., and Ross R. Cleavage of β-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell 9 (1998) 1589-1601
51. Van de Craen M., Berx G., Van den Brande I., Fiers W., Declercq W., and Vandenabeele P. Proteolytic cleavage of β-catenin by caspases: an in vitro analysis. FEBS Lett 458 (1999) 167-170
52. Jaiswal A.S., Marlow B.P., Gupta N., and Narayan S. β-Catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21 (2002) 8414-8427
53. Gillibert M., Dehry Z., Terrier M., El Benna J., and Lederer F. Another biological effect of tosylphenylalanylchloromethane (TPCK): it prevents p47phox phosphorylation and translocation upon neutrophil stimulation. Biochem J 386 (2005) 549-556
54. Shin S.Y., Kim C.G., Jho E.H., Rho M.S., Kim Y.S., Kim Y.H., and Lee Y.H. Hydrogen peroxide negatively modulates Wnt signaling through downregulation of β-catenin. Cancer Lett 212 (2004) 225-231